Atlantic salmon (Salmo salar) fed L-carnitine exhibit altered intermediary metabolism and reduced tissue lipid, but no change in growth rate.
Metabolic evidence was sought to explain the reduced body fat and increased body protein observed in Atlantic salmon fed diets supplemented with L-carnitine. By stimulating fatty acid oxidation, dietary carnitine might increase flux through pyruvate carboxylase and decrease flux through the branched-chain alpha-keto acid dehydrogenase complex, by increasing regulatory ratios of acetyl CoA:free enzyme A (CoA-SH) and ATP:ADP. Such changes could conserve nitrogen by providing more carbon for amino acid biosynthesis and by blocking oxidative loss of the branched-chain amino acids. Consistent with this hypothesis, salmon fed carnitine (23 mmol/kg diet) for 9 wk exhibited greater metabolic rates than cohorts fed a carnitine-free diet (P < 0.05) for the following: 1) 1-[14C] palmitate oxidation by liver cubes (48%) and by isolated hepatocytes (151%), 2) pyruvate-dependent [14 CO2]-fixation by isolated mitochondria (81%), 3) incorporation of 1-[14C] lactate into glucose by liver cubes (120%) and by isolated hepatocytes (210%), and 4) incorporation of [35S]-methionine into the acid-insoluble fraction of liver cubes (59%) and isolated hepatocytes (89%). Hepatic concentrations of seven amino acids, including the branched-chain amino acids, were greater (7-112%), as were the plasma concentrations of three of these (45-130%). However, 230% more enzyme in the mitochondria of carnitine-fed fish, and not a difference in the ratios of acetyl CoA:CoA-SH or ATP:ADP, appeared to account for accelerated flux through pyruvate carboxylase; flux through the dehydrogenase complex was unchanged. These results implicate induction of pyruvate carboxylase (or a reduction in turnover) and enhanced protein synthesis in the mechanism for carnitine-induced changes in gluconeogenesis and nitrogen metabolism.
Ji
H
H
Department of Biochemistry, Microbiology and Molecular Genetics, University of Rhode Island, Kingston 02881, USA.
Bradley
T M
TM
Tremblay
G C
GC
D000596:Amino Acids / Q000032:analysis; D000818:Animals; D001823:Body Composition / Q000187:drug effects* / Q000502:physiology; D002331:Carnitine / Q000032:analysis / Q000097:blood / Q000494:pharmacology*; D002469:Cell Separation; D004032:Diet / Q000662:veterinary*; D006003:Glycogen / Q000032:analysis / Q000378:metabolism; D050356:Lipid Metabolism; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000737:chemistry / Q000166:cytology / Q000648:ultrastructure; D008930:Mitochondria, Liver / Q000201:enzymology; D018482:Muscle, Skeletal / Q000737:chemistry; D009584:Nitrogen / Q000032:analysis / Q000378:metabolism; D010084:Oxidation-Reduction; D012474:Salmon / Q000254:growth & development* / Q000378:metabolism* / Q000502:physiology; D015430:Weight Gain / Q000502:physiology
D000596:Amino Acids; D008055:Lipids; D006003:Glycogen; D009584:Nitrogen; D002331:Carnitine